Abstract:Intravenous anesthesia with propofol was reported to improve cancer surgical outcomes when compared with inhalational anesthesia. However, the underlying molecular mechanisms largely remain unknown.The anti-tumor effects of propofol and the possible underlying mechanism including altered metabolic and signaling pathways were studied in the current study.The cell viability, proliferation, migration, and invasion of cancer cells were analyzed with CCK-8, Ki-67 staining, wound healing, and Transwell assay, respectively. The protein changes were analyzed with Western blot and immunofluorescent staining. The metabolomics alteration was studied with 1H-NMR spectroscopy. The gene expression regulations were analyzed with PCR gene array and qRT-PCR experiments.In this study, we found that propofol reduced cell viability and inhibited cell proliferation, migration and invasion of lung cancer cells, but not neuroglioma cells. In lung cancer cells, propofol downregulated glucose transporter 1 (GLUT1), mitochondrial pyruvate carrier 1 (MPC1), p-Akt, p-Erk1/2, and hypoxia- inducible factor 1 alpha (HIF-1 α ) expressions and upregulated pigment epithelium-derived factor (PEDF) expression. Propofol increased intracellular glutamate and glycine but decreased acetate and formate whilst increased glucose, lactate, glutamine, succinate, pyruvate, arginine, valine, isoleucine, and leucine and glycerol, and decreased acetate, ethanol, isopropanol in the culture media of lung cancer cells. Furthermore, VEGFA, CTBP1, CST7, CTSK, CXCL12, and CXCR4 gene expressions were downregulated, while NR4A3, RB1, NME1, MTSS1, NME4, SYK, APC, and FAT1 were upregulated following the propofol treatment. Consistent with the phenotypical changes, these molecular and metabolic changes were not found in the neuroglioma cells.Our findings indicated anti-tumor effects of propofol on the lung cancer but not brain cancer, through the regulation of tumor metastasis-related genes, multi-cellular signaling and cellular metabolism.<ol class="links-for-figure"><li><a class="anchor download-link u-font-sans" href="https://ars.els-cdn.com/content/image/1-s2.0-S2090123220302575-ga1_lrg.jpg">Download : Download high-res image (102KB)</a></li><li><a class="anchor download-link u-font-sans" href="https://ars.els-cdn.com/content/image/1-s2.0-S2090123220302575-ga1.jpg">Download : Download full-size image</a></li></ol>

Propofol Inhibits Breast Cancer Cells Proliferation and Migration by Down-Regulating TGFβ1/Smad2/MMP-9 Signal

Propofol Inhibits Proliferation, Migration, Invasion and Promotes Apoptosis Through Down-Regulating Mir-374A in Hepatocarcinoma Cell Lines

Propofol Exerts Anti-Hepatocellular Carcinoma by Microvesicle-Mediated Transfer of Mir-142-3p from Macrophage to Cancer Cells

Propofol Inhibits the Adhesion of Hepatocellular Carcinoma Cells by Upregulating Microrna-199A and Downregulating MMP-9 Expression.

Effects of Propofol on Colon Cancer Metastasis Through STAT3/HOTAIR Axis by Activating WIF‐1 and Suppressing Wnt Pathway

Propofol Inhibits Cancer Malignancy by Disturbing Glucose Metabolism Through Hypoxia-Inducible Factor-1Α and Pigment Epithelium-Derived Factor Modulation

Repurposing propofol for breast cancer therapy through promoting apoptosis and arresting cell cycle

Propofol Induces ROS-mediated Intrinsic Apoptosis and Migration in Triple-Negative Breast Cancer Cells.

Propofol induces apoptosis of hepatocellular carcinoma cells by upregulation of microRNA-199a expression.

Propofol modulates the proliferation, invasion and migration of bladder cancer cells through the miR‐145‐5p/TOP2A axis

Propofol Reduces MMPs Expression by Inhibiting NF-κB Activity in Human MDA-MB-231 Cells.

RETRACTED: Propofol Inhibits Proliferation, Migration and Invasion of Gastric Cancer Cells by Up-Regulating Microrna-195

Propofol Attenuates Lung but not Brain Cancer Cell Malignancy through Metabolism and Cell Signaling Modulation&nbsp;In Vitro

Propofol overcome Tamoxifen resistance in breast cancer by modulating tumorogenesis, immune response and metabolism

Anesthetic Propofol Promotes Tumor Metastasis in Lungs via GABA<sub>A</sub>R‐Dependent TRIM21 Modulation of Src Expression

Anesthetic Propofol Promotes Tumor Metastasis in Lungs Via GABAAR‐Dependent TRIM21 Modulation of Src Expression

Suppression of Cell Invasion and Migration by Propofol Are Involved in Down-Regulating Matrix Metalloproteinase-2 and P38 Mapk Signaling in A549 Human Lung Adenocarcinoma Epithelial Cells

Propofol Disrupts Cell Carcinogenesis and Aerobic Glycolysis by Regulating Circtada2a/mir-455-3p/foxm1 Axis in Lung Cancer

Lung but not brain cancer cell malignancy inhibited by commonly used anesthetic propofol during surgery: Implication of reducing cancer recurrence risk

Propofol suppresses the growth and invasion of cervical carcinoma cells by inhibiting MIR155HG

Propofol Inhibits Proliferation and Augments the Anti-Tumor Effect of Doxorubicin and Paclitaxel Partly Through Promoting Ferroptosis in Triple-Negative Breast Cancer Cells